Svati Hasmukh Shah

Shah

Professor of Medicine

Appointments and Affiliations

  • Professor of Medicine
  • Professor of Biostatistics and Bioinformatics
  • Member in the Duke Clinical Research Institute
  • Member of Duke Molecular Physiology Institute

Contact Information

  • Office Location: DUMC Box 3445, Durham, NC 27710
  • Office Phone: (919) 684-1808
  • Email Address: svati.shah@duke.edu

Education

  • Duke University, 2005
  • Children's Hospital Boston, 2001
  • M.D. University of Washington, 1998
  • M.H.S. Johns Hopkins University, 1994

Awards, Honors, and Distinctions

  • Judson Daland Prize. American Philosophical Society. 2011

In the News

Representative Publications

  • Edmonston, DL; Matsouaka, R; Shah, SH; Rajagopal, S; Wolf, M, Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload., Am J Cardiol, vol 159 (2021), pp. 113-120 [10.1016/j.amjcard.2021.08.016] [abs].
  • White, PJ; McGarrah, RW; Herman, MA; Bain, JR; Shah, SH; Newgard, CB, Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street., Molecular Metabolism, vol 52 (2021) [10.1016/j.molmet.2021.101261] [abs].
  • Colaco, NA; Wang, TS; Ma, Y; Scherzer, R; Ilkayeva, OR; Desvigne-Nickens, P; Braunwald, E; Hernandez, AF; Butler, J; Shah, SH; Shah, SJ; Hsue, PY, Transmethylamine-N-Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV., Journal of the American Heart Association, vol 10 no. 16 (2021) [10.1161/JAHA.120.020499] [abs].
  • Truby, LK; Kwee, LC; Agarwal, R; Grass, E; DeVore, AD; Patel, CB; Chen, D; Schroder, JN; Bowles, D; Milano, CA; Shah, SH; Holley, CL, Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation., J Heart Lung Transplant (2021) [10.1016/j.healun.2021.07.024] [abs].
  • Truby, LK; Regan, JA; Giamberardino, SN; Ilkayeva, O; Bain, J; Newgard, CB; O'Connor, CM; Felker, GM; Kraus, WE; McGarrah, RW; Shah, SH, Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy., Cardiovascular Diabetology, vol 20 no. 1 (2021) [10.1186/s12933-021-01353-z] [abs].